231 UPDATE OF RESPONSE TO TREATMENT WITH AZACITIDINE AND DECITABINE IN HIGH-RISK MDS PATIENTS FROM THE DUESSELDORF MDS REGISTRY – 10 YEARS EXPERIENCE WITH HYPOMETHYLATING TREATMENT. Issue 1 (April 2015) - Neukirchen, J.